Medication Guide - 6/4/2021

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Reyvow Lasmiditan Succinate TABLET;ORAL 211280 ELI LILLY AND CO 06/03/2021 Dolophine Hydrochloride Methadone Hydrochloride SYRUP;ORAL 006134 HIKMA 06/02/2021 Dolophine Hydrochloride Methadone Hydrochloride TABLET;ORAL 006134 HIKMA 06/02/2021 Dolophine Hydrochloride Methadone Hydrochloride SYRUP;ORAL 006134 HIKMA 06/02/2021 Dolophine Hydrochloride Methadone Hydrochloride TABLET;ORAL 006134 HIKMA 06/02/2021 Morphine Sulfate Morphine Sulfate SOLUTION;ORAL 022195 HIKMA 06/02/2021 Morphine Sulfate Morphine Sulfate SOLUTION;ORAL 022195 HIKMA 06/02/2021 Morphine Sulfate Morphine Sulfate TABLET;ORAL 022207 HIKMA 06/02/2021 Morphine Sulfate Morphine Sulfate TABLET;ORAL 022207 HIKMA 06/02/2021 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA